Prima Announces New Product Candidate IMP761 -- A LAG-3 Agonist Antibody
SYDNEY, AUSTRALIA--(Marketwired - Jan 2, 2017) - Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) ("Prima", the "Company") announces that it has developed a new early stage product candidate, a humanised IgG4 monoclonal antibody to be known …